Bisphosphonates induce apoptosis in human myeloma cell lines: A novel anti-tumour activity

British Journal of Haematology

Volumn 98, Issue 3, 1997, Pages 665-672

  Shipman, Claire M ^a   Rogers, Michael J ^a   Apperley, Jane F ^b   Russell, R Graham G ^a   Croucher, Peter I ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Bisphosphonate; Cell cycle; Myeloma

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; DNA FRAGMENT; INCADRONIC ACID; PAMIDRONIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL COUNT; CELL CYCLE; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; OSTEOLYSIS; PRIORITY JOURNAL;

EID: 0030931858     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.2713086.x     Document Type: Article

References (31)

1. Bataille, R., Chappard, D. & Basle, M. (1995) Excessive bone resorption in human plasmacytomas: direct induction by tumour cells in vivo. British Journal of Haematology, 90, 721-724.
2. Berenson, J., Lichtenstein, A., Porter, L., Dimopoulos, M., Bordoni, R., George, S., Lipton, A., Keller, A., Ballester, O., Kovacs, M., Blacklock, H., Bell, R., Simeone, J., Reitsma, D., Heffernan, M., Seaman, J. & Knight, R. (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. New England Journal of Medicine, 334, 488-493.
3. Berenson, J., Lichtenstein, A., Porter, L. George, S., Lipton, A., Keller, A., Heffernan, M., Seaman, J. & Knight, R. (1995) Long-term pamidronate disodium therapy leads to a reduction of skeletal related episodes (SREs) in stage III multiple myeloma patients and an improvement in survival in those on salvage therapy. (Abstract). Bone, 17, 614.
4. Boonekamp, P., van der Wee-Pals, L.M., van Wijk-van Lennep, M.M.L., Thesing, C.W. & Bijvoet, O.L. (1986) Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone and Mineral, 1, 27-39.
5. Cecchini, M.G., Felix, R., Fleisch, H. & Cooper, P.H. (1987) Effects of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages. Journal of Bone and Mineral Research, 2, 135-142.
6. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M.A., Lassota, P. & Traganos, F. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808.
7. Fast, D.K., Felix, R., Dowse, C., Neuman, W.F. & Fleisch, H. (1978) The effects of diphosphonates on the growth and glycolysis of connective-tissue cells in culture. Biochemical Journal, 172, 97-107.
8. Fleisch, H. (1991) Bisphosphonates: pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs, 42, 919-944.
9. Frith, J.C., Mönkkönen, J., Russell, R.G.G., Blackburn, G.M., Watts, D.J. & Rogers, M.J. (1996) Clodronate and liposome encapsulated clodronate can be metabolised to a non-hydrolysable ATP analogue by mammalian cells in vitro. (Abstract). Journal of Bone and Mineral Research, 11, 1813.
10. Geddes, A.D., D'Souza, S.M., Ebetino, F.H. & Ibbotson, K.J. (1994) Bisphosphonates: structure-activity relationships and therapeutic implications. Bone and Mineral Research, 8, 265-306.
11. Hughes, D.E., Wright, K.R., Uy, H., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. & Boyce, B.F. (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vitro. Journal of Bone and Mineral Research, 10, 1478-1487.
12. Hughes, D.E., MacDonald, B.R., Russell, R.G.G. & Gowen, M. (1989) Inhibition of osteoclast-like cell function by bisphosphonates in long-term cultures of human bone marrow. Journal of Clinical Investigation, 83, 1930-1935.
13. Jantunen, E. & Laakso, M. (1996) Bisphosphonates in multiple myeloma: current status, future perspectives. British Journal of Haematology, 93, 501-506.
14. Lahtinen, R., Laakso, M. Palva, I., Virkkunen, P. & Elomaa, I. (1992) Randomised, placebo controlled multicentre trial of clodronate in multiple myeloma. Lancet, 340, 1049-1052.
15. McCloskey, E.V., MacLennan, I.C.M., Drayson, M., Chapman, C., Dunn, J. & Kanis, J.A. (1996) Effect of clodronate on morbidity and mortality in myelomatosis. (Abstract). Annals of Oncology, 7, (Suppl. 5), Abstr. 4120.
16. Morton, A. (1995) The role of bisphosphonates in patients with bony metastases. The Cancer Journal, 8, 231-233.
17. Mundy, G.R., Raisz, L.G., Cooper, R.A., Schechter, G.P. & Salmon, S. (1974) Evidence for the secretion of an osteoclast stimulating factor in myeloma. New England Journal of Medicine, 291, 1041-1046.
18. 2MDP) on rat macrophage-mediated bone resorption in vitro. Journal of Clinical Investigation, 70, 927-932.
19. Rodan, G.A. & Fleisch, H.A. (1996) Bisphosphonates: mechanisms of action. Journal of Clinical Investigation, 97, 2692-2696.
20. Rogers, M.J., Chilton, K.M., Coxon, F.P. Lawry, J., Smith, M.O., Suri, S. & Russell, R.G.G. (1996) Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. Journal of Bone and Mineral Research, 13, 1482-1491.
21. Rogers, M.J. & Russell, R.G.G. (1996) Mechanisms of action of bisphosphonates as inhibitors of bone resorption. The Molecular Biology of Paget's Disease (ed. by P. T. Sharpe), p. 147. R. G. Landes Co., Austin, Texas.
22. Rogers, M.J., Watts, D.J., Russell, R.G.G., R. X., Xiong, X., Blackburn, G.M., Bayless, A.V. & Ebetino, F.H. (1994) Inhibitory effects of bisphosphonates on growth of amoebae of the cellular slime mould Dictyostelium discoideum. Journal of Bone and Mineral Research, 9, 1029-1039.
23. Sahni, M., Guenther, H.L., Fleisch, H., Collin, P. & Martin, T.J. (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. Journal of Clinical Investigation, 91, 2004-2011.
24. Sasaki, A., Boyce, B.F., Story, B., Wright, K.R., Chapman, M., Boyce, R., Mundy, G.R. & Yoneda, T. (1995) Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Research, 55, 3551-3557.
25. Sato, M., Grasser, W., Endo, N., Akins, R., Simmons, H., Thompson, D.D., Golub, E. & Rodan, G.A. (1991) Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. Journal of Clinical Investigation, 88, 2095-2105.
26. Taube, T., Beneton, M.N.C., McCloskey, E.V., Rogers, S., Greaves, M. & Kanis, J.A. (1992) Abnormal bone remodelling in patients with myelomatosis and normal biochemical indices of bone resorption. European Journal of Haematology, 49, 192-198.
27. Valentin-Opran, A., Charhon, S., Meunier, P.J., Edouard, C.M. & Arlot, M.E. (1982) Quantitative histology of myeloma-induced bone changes. British Journal of Haematology, 52, 601-610.
28. Van der Pluijm, G., Vloedgraven, H., Van Beek, E., van der Wee-Pals, L., Löwik, C. & Papapoulos, S. (1996) Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro. Journal of Clinical Investigation, 98, 698-705.
29. Wingen, F., Klenner, T. & Schmähl, D. (1989) Are all anticancer effects of pamidronate (APD) and related compounds bone-mediated? The Management of Bone Metastases and Hypercalcaemia by Osteoclast Inhibition, Fifth European Conference on Clinical Oncology, p. 111. Hogrefe and Huber, Bern.
30. Wingen, F., Pool, B.L., Klein, P., Klenner, T. & Schmähl, D. (1988) Anticancer activity of bisphosphonic acids in methylnitrosourea-induced mammary carcinoma of the rat: benefit of combining bisphospbonates with cytostatic agents. Investigational New Drugs, 6, 155-167.
31. Wyllie, A., Kerr, J.F.R. & Currie, A.R. (1980) Cell death: the significance of apoptosis. International Review of Cytology, 68, 251-306.